Product
APL-130277
1 clinical trial
1 indication
Clinical trial
An Open-Label, Randomized, Crossover Trial Utilizing a Single-Blinded Rater to Evaluate APL-130277 Compared to Subcutaneous Apomorphine in Levodopa Responsive Subjects With Parkinson's Disease Complicated by Motor FluctuationsStatus: Completed, Estimated PCD: 2021-08-11